298 related articles for article (PubMed ID: 28315274)
1. Role of σ
Maurice T; Goguadze N
Adv Exp Med Biol; 2017; 964():213-233. PubMed ID: 28315274
[TBL] [Abstract][Full Text] [Related]
2. Sigma-1 (σ
Maurice T; Goguadze N
Handb Exp Pharmacol; 2017; 244():81-108. PubMed ID: 28275911
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotection in non-transgenic and transgenic mouse models of Alzheimer's disease by positive modulation of σ
Maurice T; Volle JN; Strehaiano M; Crouzier L; Pereira C; Kaloyanov N; Virieux D; Pirat JL
Pharmacol Res; 2019 Jun; 144():315-330. PubMed ID: 31048034
[TBL] [Abstract][Full Text] [Related]
4. Anti-amnesic and neuroprotective potentials of the mixed muscarinic receptor/sigma 1 (σ1) ligand ANAVEX2-73, a novel aminotetrahydrofuran derivative.
Villard V; Espallergues J; Keller E; Vamvakides A; Maurice T
J Psychopharmacol; 2011 Aug; 25(8):1101-17. PubMed ID: 20829307
[TBL] [Abstract][Full Text] [Related]
5. Protection by sigma-1 receptor agonists is synergic with donepezil, but not with memantine, in a mouse model of amyloid-induced memory impairments.
Maurice T
Behav Brain Res; 2016 Jan; 296():270-278. PubMed ID: 26386305
[TBL] [Abstract][Full Text] [Related]
6. Amyloid toxicity is enhanced after pharmacological or genetic invalidation of the σ
Maurice T; Strehaiano M; Duhr F; Chevallier N
Behav Brain Res; 2018 Feb; 339():1-10. PubMed ID: 29129596
[TBL] [Abstract][Full Text] [Related]
7. Nicotinic Cholinergic Mechanisms in Alzheimer's Disease.
Shen J; Wu J
Int Rev Neurobiol; 2015; 124():275-92. PubMed ID: 26472533
[TBL] [Abstract][Full Text] [Related]
8. The sigma1 protein as a target for the non-genomic effects of neuro(active)steroids: molecular, physiological, and behavioral aspects.
Monnet FP; Maurice T
J Pharmacol Sci; 2006 Feb; 100(2):93-118. PubMed ID: 16474209
[TBL] [Abstract][Full Text] [Related]
9. AF710B, a Novel M1/σ1 Agonist with Therapeutic Efficacy in Animal Models of Alzheimer’s Disease.
Fisher A; Bezprozvanny I; Wu L; Ryskamp DA; Bar-Ner N; Natan N; Brandeis R; Elkon H; Nahum V; Gershonov E; LaFerla FM; Medeiros R
Neurodegener Dis; 2016; 16(1-2):95-110. PubMed ID: 26606130
[TBL] [Abstract][Full Text] [Related]
10. Dementia of Alzheimer's disease and other neurodegenerative disorders--memantine, a new hope.
Sonkusare SK; Kaul CL; Ramarao P
Pharmacol Res; 2005 Jan; 51(1):1-17. PubMed ID: 15519530
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective action of diazepam at very low and moderate doses in Alzheimer's disease model rats.
Pilipenko V; Narbute K; Pupure J; Rumaks J; Jansone B; Klusa V
Neuropharmacology; 2019 Jan; 144():319-326. PubMed ID: 30408486
[TBL] [Abstract][Full Text] [Related]
12. The interaction between neuroactive steroids and the sigma1 receptor function: behavioral consequences and therapeutic opportunities.
Maurice T; Urani A; Phan VL; Romieu P
Brain Res Brain Res Rev; 2001 Nov; 37(1-3):116-32. PubMed ID: 11744080
[TBL] [Abstract][Full Text] [Related]
13. Small molecule modulator of sigma 2 receptor is neuroprotective and reduces cognitive deficits and neuroinflammation in experimental models of Alzheimer's disease.
Yi B; Sahn JJ; Ardestani PM; Evans AK; Scott LL; Chan JZ; Iyer S; Crisp A; Zuniga G; Pierce JT; Martin SF; Shamloo M
J Neurochem; 2017 Feb; 140(4):561-575. PubMed ID: 27926996
[TBL] [Abstract][Full Text] [Related]
14. Neuroactive neurosteroids as endogenous effectors for the sigma1 (sigma1) receptor: pharmacological evidence and therapeutic opportunities.
Maurice T; Phan VL; Urani A; Kamei H; Noda Y; Nabeshima T
Jpn J Pharmacol; 1999 Oct; 81(2):125-55. PubMed ID: 10591471
[TBL] [Abstract][Full Text] [Related]
15. The attenuation of learning impairments induced after exposure to CO or trimethyltin in mice by sigma (sigma) receptor ligands involves both sigma1 and sigma2 sites.
Maurice T; Phan VL; Noda Y; Yamada K; Privat A; Nabeshima T
Br J Pharmacol; 1999 May; 127(2):335-42. PubMed ID: 10385231
[TBL] [Abstract][Full Text] [Related]
16. Anti-amnesic effect of neurosteroid PREGS in Aβ25-35-injected mice through σ1 receptor- and α7nAChR-mediated neuroprotection.
Yang R; Chen L; Wang H; Xu B; Tomimoto H; Chen L
Neuropharmacology; 2012 Nov; 63(6):1042-50. PubMed ID: 22884465
[TBL] [Abstract][Full Text] [Related]
17. Improving Alzheimer's Disease-Related Cognitive Deficits with sigma1 Receptor Agonists.
Maurice T
Drug News Perspect; 2002 Dec; 15(10):617-625. PubMed ID: 12677246
[TBL] [Abstract][Full Text] [Related]
18. Simvastatin enhances learning and memory independent of amyloid load in mice.
Li L; Cao D; Kim H; Lester R; Fukuchi K
Ann Neurol; 2006 Dec; 60(6):729-39. PubMed ID: 17192930
[TBL] [Abstract][Full Text] [Related]
19. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
[TBL] [Abstract][Full Text] [Related]
20. Artemisinin B Improves Learning and Memory Impairment in AD Dementia Mice by Suppressing Neuroinflammation.
Qiang W; Cai W; Yang Q; Yang L; Dai Y; Zhao Z; Yin J; Li Y; Li Q; Wang Y; Weng X; Zhang D; Chen Y; Zhu X
Neuroscience; 2018 Dec; 395():1-12. PubMed ID: 30399421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
